Literature DB >> 6974718

Clinical experience with deamino-8-D-AGR-Vasopressin (DDAVP) in patients with Factor VIII deficiency.

J D Sweeney, P Crosby, S R McCann, I J Temperley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6974718     DOI： 10.1007/BF02938244

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  4 in total

1.  Letter: A method for assaying von Willebrand factor (ristocetin cofactor).

Authors:  D E Macfarlane; J Stibbe; E P Kirby; M B Zucker; R A Grant; J McPherson
Journal:  Thromb Diath Haemorrh       Date:  1975-09-30

2.  1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.

Authors:  P M Mannucci; Z M Ruggeri; F I Pareti; A Capitanio
Journal:  Lancet       Date:  1977-04-23       Impact factor: 79.321

3.  Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.

Authors:  C A Ludlam; I R Peake; N Allen; B L Davies; R A Furlong; A L Bloom
Journal:  Br J Haematol       Date:  1980-07       Impact factor: 6.998

4.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.